Clinical Trial Update: Fetal Alcohol Spectrum Disorder : Clinical Description and Search for Epigenetic Biomarker (EPI-TSAF) [NA]

View source ↗

Summary

The clinical trial EPI-TSAF investigating fetal alcohol spectrum disorders and potential epigenetic biomarkers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Alcohol Spectrum Disorders

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Fetal Alcohol Spectrum Disorders | NA | Status: COMPLETED